Effective Consent Made Easier Under the NOC Regulations
Canadian Intellectual Property Blog
DECEMBER 7, 2020
Case introduction: The Patented Medicines (Notice of Compliance) Regulations (“NOC Regulations”) permit the Minister of Health (“Minister”) to issue a notice of compliance (“NOC”) to a generic company where a patentee’s effective consent is obtained. Effective consent under the NOC Regulations requires the patentee’s consent for the making, constructing, using or selling of a drug in Canada (“Activities”).
86 
Let's personalize your content